No CrossRef data available.
Article contents
Getting More Value from Outcomes-Based Contracts
Published online by Cambridge University Press: 01 January 2021
Abstract
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Independent Articles: Commentary
- Information
- Journal of Law, Medicine & Ethics , Volume 46 , Issue 4: Next Steps in Health Reform , Winter 2018 , pp. 964 - 966
- Copyright
- Copyright © American Society of Law, Medicine and Ethics 2018
References
Seeley, E., Chimonas, S., and Kesselheim, A.S., “Can Outcomes-Based Pharmaceutical Contracts Reduce Drug Prices in the US?: A Mixed Methods Assessment, Journal of Law, Medicine & Ethics 46, no. 4 (2018): 952–963.Google Scholar
Duhig, A.M., Saha, S., Smith, S., Kaufman, S., and Hughes, J., “The Current Status of Outcomes-Based Contracting for Manufacturers and Payers: An AMCP Membership Survey,” Journal of Managed Care & Specialty Pharmacy 24, no 5 (2018): 410–415; Duke Robert J. Margolis MD Center for Health Policy, Center for Health Policy, Overcoming Legal and Regulatory Hurdles to Value-Based Payment Arrangements for Medical Products, December 2017.CrossRefGoogle Scholar
Seeley, supra note 1.Google Scholar
Dubois, R., Sherman, M., and Spurr, R., “More than Meets the Eye — Value-Based Contracts are More Prevalent than We Think,” paper presented at: AMCP Managed Care & Specialty Pharmacy Annual Meeting 2018, April 25, 2018, Boston, MA.Google Scholar
Seeley, supra note 1.Google Scholar
Seeley, supra note 1.Google Scholar
Seeley, supra note 1.Google Scholar
Seeley, supra note 1.Google Scholar
Nazareth, T., Ko, J.J., Sasane, R., et al., “Outcomes-Based Contracting Experience: Research Findings from U.S. and European Stakeholders, Journal of Managed Care & Specialty Pharmacy 23, no. 10 (2017):1018–1026.Google ScholarPubMed
Seeley, supra note 1.Google Scholar